Carlos Gustavo Wambier

InstitutionState University of Ponta Grossa
AddressBrazil
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 31 Covid-19 publications, with a maximum of 5 publications in April 2020 and July 2020
    All Publications
    Bar chart showing 52 publications over 10 distinct years, with a maximum of 20 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abrantes TF, Artounian KA, Falsey R, Simão JCL, Vañó-Galván S, Ferreira SB, Davis TL, Ridenour W, Goren A, Tosti A, Wambier CG. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021 10; 85(4):975-976. PMID: 34302903.
      Citations: 1     Fields:    Translation:Humans
    2. McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Front Med (Lausanne). 2021; 8:668698. PMID: 34350193.
      Citations: 6     
    3. Cadegiani FA, Goren A, Wambier CG, McCoy J. Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New Microbes New Infect. 2021 Sep; 43:100915. PMID: 34249367.
      Citations: 4     
    4. Ghanian S, Wambier CG. Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males". EBioMedicine. 2021 06; 68:103425. PMID: 34134086.
      Citations:    Fields:    Translation:Humans
    5. MacDonald S, Matos de Oliveira A, Wambier CG. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter. J Urol. 2021 09; 206(3):784-785. PMID: 33998834.
      Citations:    Fields:    Translation:Humans
    6. Nguyen C, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Wambier CG, Cadegiani FA, Goren A. SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Ann Thyroid. 2022 Mar; 6. PMID: 34151187.
      Citations:    
    7. MacDonald S, Wambier CG. Letter to the Editor on "COVID-19 Infection in Men on Testosterone Replacement Therapy". J Sex Med. 2021 06; 18(6):1141-1142. PMID: 33962880.
      Citations: 1     Fields:    Translation:Humans
    8. Cadegiani F, Lin EM, Goren A, Wambier CG. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26; 14(2). PMID: 33637513.
      Citations: 6     Fields:    Translation:Humans
    9. Chesnut WM, MacDonald S, Wambier CG. Could diet and exercise reduce risk of COVID-19 syndemic? Med Hypotheses. 2021 Mar; 148:110502. PMID: 33529978.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    10. Wambier CG. Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". Int J Antimicrob Agents. 2021 Jan; 57(1):106175. PMID: 33408021.
      Citations: 2     Fields:    Translation:Humans
    11. Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J. Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster. Med Hypotheses. 2021 01; 146:110439. PMID: 33308937.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    12. Wambier CG, Vaño-Galván S, Goren A. Reply to comment on: The Gabrin sign. J Am Acad Dermatol. 2021 03; 84(3):e149-e150. PMID: 33253847.
      Citations:    Fields:    
    13. McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. J Eur Acad Dermatol Venereol. 2021 Apr; 35(4):e243-e246. PMID: 33135263.
      Citations: 18     Fields:    Translation:Humans
    14. Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG. Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):e101-e104. PMID: 33089570.
      Citations: 10     Fields:    Translation:Humans
    15. McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e15-e17. PMID: 32977355.
      Citations: 10     Fields:    Translation:Humans
    16. Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e13-e15. PMID: 32977363.
      Citations: 19     Fields:    Translation:Humans
    17. Wambier CG, McCoy J, Goren A. Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals. J Am Acad Dermatol. 2020 12; 83(6):e401-e402. PMID: 32926978.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    18. Wambier CG. Reply to: "Comment on 'Androgenetic alopecia present in the majority of patients hospitalized with COVID-19'". J Am Acad Dermatol. 2021 01; 84(1):e53-e54. PMID: 32860919.
      Citations:    Fields:    Translation:HumansPHPublic Health
    19. Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A. Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign. J Am Acad Dermatol. 2020 12; 83(6):e453-e454. PMID: 32735970.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    20. Lim RK, Wambier CG, Goren A. Are night shift workers at an increased risk for COVID-19? Med Hypotheses. 2020 Nov; 144:110147. PMID: 32758906.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    21. Cadegiani FA, Wambier CG, Goren A. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Front Med (Lausanne). 2020; 7:453. PMID: 32850920.
      Citations: 12     
    22. Cadegiani FA, Goren A, Wambier CG. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses. 2020 Oct; 143:110112. PMID: 32721806.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    23. Goren A, Wambier CG, McCoy J, Shapiro J, Vaño-Galván S, Herrera S, Glode LM. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall? J Biol Regul Homeost Agents. 2020 Jul-Aug,; 34(4):1455-1457. PMID: 32700513.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    24. McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Ramos PM, Washenik K, Andrade M, Herrera S, Goren A. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020 Jul; 19(7):1542-1543. PMID: 32333494.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    25. Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol. 2020 Aug; 83(2):680-682. PMID: 32446821.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    26. Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020 11; 81(7):771-776. PMID: 32412125.
      Citations: 47     Fields:    Translation:HumansPHPublic Health
    27. Cavanagh G, Wambier CG. Reply to: "Personal protective equipment recommendations based on COVID-19 route of transmission". J Am Acad Dermatol. 2020 07; 83(1):e47. PMID: 32344068.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    28. Goren A, Vaño-Galván S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washenik K. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020 Jul; 19(7):1545-1547. PMID: 32301221.
      Citations: 56     Fields:    Translation:HumansPHPublic Health
    29. Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020 Jul; 83(1):308-309. PMID: 32283245.
      Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
    30. Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020 Jul; 33(4):e13365. PMID: 32237190.
      Citations: 17     Fields:    Translation:HumansAnimalsPHPublic Health
    31. Cavanagh G, Wambier CG. Rational hand hygiene during the coronavirus 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020 06; 82(6):e211. PMID: 32268168.
      Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
    Wambier's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (202)
    Explore
    _
    Co-Authors (85)
    Explore
    _
    Similar People (60)
    Explore
    _